title: [Marked efficacy of multimodality therapy for ureteral cancer producing granulocyte colony-stmimulating factor].
abstract: A 69-year-old man was admitted with the chief complaint of macroscopic hematuria. Computerized tomography (CT) and ureteroscopy showed right ureter cancer. Right nephroureterectomy and partial cystectomy were performed. Histological examination revealed urothelial carcinoma of ureter (Grade3, pT3, INFbeta, ly1). The patient underwent two courses of adjuvant chemotherapy with gemcitabine and cisplatin. Three months later, abdominal CT showed a mass in his right obturatorius area. The patient's white blood cell count was 34,140 cells/microl. Additionally serum analysis revealed high value of granulocyte colony stimulating factor (G-CSF), 596 pg/ml with no obvious focus. After being diagnosed with recurrent ureteral cancer producing G-CSF, the patient underwent secondary chemotherapy with gemcitabine and docetaxel. After three courses of chemotherapy, CT revealed a marked decrease in tumor size, and the value of G-CSF declined at 31 pg/nl. Subsequently, radiotherapy (60 Gy) was administered. The patient has been alive for 16 months.
authors.forename: Shunichiro
authors.initials: S
authors.lastname: Nomura
authors.forename: Kaoru
authors.initials: K
authors.lastname: Nemoto
authors.forename: Go
authors.initials: G
authors.lastname: Shioji
authors.forename: Takafumi
authors.initials: T
authors.lastname: Miura
authors.forename: Narumi
authors.initials: N
authors.lastname: Tsuboi
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Abe
authors.forename: Yukihiro
authors.initials: Y
authors.lastname: Kondo
mesh_terms: D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002277:Carcinoma / Q000378:metabolism / Q000628:therapy*; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077143:Docetaxel; D016179:Granulocyte Colony-Stimulating Factor / Q000096:biosynthesis*; D006801:Humans; D008297:Male; D043823:Taxoids / Q000008:administration & dosage; D014516:Ureteral Neoplasms / Q000378:metabolism / Q000628:therapy*; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D043823:Taxoids; D003841:Deoxycytidine; D016179:Granulocyte Colony-Stimulating Factor; D000077143:Docetaxel; D000093542:Gemcitabine